Zivo Bioscience, Inc. (ZIVO) › Operating IncomeZivo Bioscience, Inc. (ZIVO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$4.06M2011: -$1.94M2012: -$2.08M2013: -$3.11M2014: -$5.15M2015: -$3.06M2016: -$3.49M2017: -$6.33M2018: -$6.13M2019: -$8.35M2020: -$8.56M2021: -$8.65M2022: -$8.73M2023: -$7.26M2024: -$13.36M-$13.36M2010Operating Income (USD)2024Fiscal YearOperating IncomeChange YoY2024-$13.36M-84.0%2023-$7.26M+16.8%2022-$8.73M-1.0%2021-$8.65M-1.0%2020-$8.56M-2.4%2019-$8.35M-36.2%2018-$6.13M+3.2%2017-$6.33M-81.4%2016-$3.49M-14.2%2015-$3.06M+40.7%2014-$5.15M-65.7%2013-$3.11M-49.5%2012-$2.08M-7.3%2011-$1.94M+52.3%2010-$4.06M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share